Emily Mullin Associate Editor, Biomedicine
I am MIT Technology Review’s associate editor for biomedicine. I report from Washington, D.C., where I look for stories about how new technology is making us healthier and our medicine better. I am particularly interested in how these advances… More are affecting real people. Previously, I was a contributor at Forbes, and before that, an associate editor at FierceBiotech. Get in touch at [email protected].
So far, they said, “there isn’t a simple or obvious explanation for how this outbreak occurred within the supply chain. If the explanation was as simple as a single farm, or a single processor or distributor, we would have already figured that out.”
[email protected] | 254-501-7554